Table 1 Baseline characteristics of patients with and without a MACCE after CABG surgery

Age, M ± SD

64.7 ± 10.6

63.7 ± 10.5

67.8 ± 10.4

.04

Female

33 (20.9)

26 (21.5)

7 (18.9)

.74

Aboriginal

6 (3.8)

3 (2.5)

3 (8.1)

.14

BMI, M ± SD

29.1 ± 5.2

29.3 ± 5.0

28.6 ± 5.6

.47

Concomitant valvular procedure

18 (11.4)

12 (9.9)

6 (16.2)

.29

Urgent surgery

34 (21.5)

28 (23.1)

6 (16.2)

.37

Previous MI <30 days

51 (32.3)

39 (32.2)

12 (32.4)

.98

LVEF 45 – 60 %

33 (20.9)

22 (18.2)

11 (29.7)

.39

30 – 45 %

12 (7.4)

9 (7.4)

3 (8.1)

<30 %

6 (3.3)

4 (3.3)

2 (5.4)

Hypertension

102 (64.6)

73 (60.3)

29 (78.4)

.04

Hypercholesterolemia

118 (74.7)

91 (75.2)

27 (73.0)

.79

Diabetes, Type 1

2 (1.3)

2 (1.7)

-

.63

Type 2

48 (30.4)

38 (31.4)

10 (27.0)

Chronic lung disease

33 (20.9)

27 (22.3)

6 (16.2)

.43

Renal disease

11 (7.0)

6 (5.0)

5 (13.5)

.07

Heart failure

40 (25.3)

26 (21.5)

14 (37.8)

.04

Peripheral vascular disease

18 (11.4)

10 (8.3)

8 (21.6)

.03

Cerebrovascular disease

16 (10.1)

12 (9.9)

4 (10.8)

.88

Tobacco smoking

94 (59.5)

73 (60.3)

21 (56.8)

.70

SSRI

6 (3.8)

4 (3.3)

2 (5.4)

.63

Tricyclic

3 (1.9)

1 (0.8)

2 (5.4)

.14

Aspirin

122 (77.2)

91 (75.2)

31 (83.8)

.28

EuroSCORE, Median (IQR)

2.6 (1.5 – 4.7)

2.5 (1.5 – 4.4)

3.1 (2.0 – 6.6)

.24

Pre-CPB Hb, M ± SD

13.9 ± 1.7

14.0 ± 1.7

13.5 ± 2.0

.17

Minutes spent on CPB Median (IQR)

56.0 (42.8 – 73.0)

57.0 (46.0 – 73.0)

52.0 (36.5 – 74.5)

.30

ICU LOS, median hours (IQR)

25.7 (23 – 47.5)

25.7 (23.0 – 48.4)

25.7 (23.6 – 27.6)

.97

ICU intubation, median hours (IQR)

12.5 (10.1 – 17.0)

12.2 (9.6 – 16.4)

14.2 (11.5 – 22.0)

.13